Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Asian Pac J Cancer Prev ; 24(2): 659-665, 2023 Feb 01.
Article in English | MEDLINE | ID: mdl-36853317

ABSTRACT

BACKGROUND: Chlamydia pneumoniae (C. pneumoniae) is a respiratory pathogen associated with chronic inflammatory and its detection in human lung cancer suggests its involvement in cancerogenesis. Our study aimed to evaluate the association between C. pneumoniae  infection and Lung Cancer disease in Moroccans patients and control cohorts, through a molecular investigation. METHODS: The study comprised 42 lung cancer patients and 43 healthy controls. All participants provided demographics, Clinical, and Toxic behaviors datas, and a peripheral blood sample for testing, a Nested Polymerase Chain Reaction (PCR) was performed for C. pneumoniae Deoxyribonucleic acid (DNA) detection. Statistical analysis was performed using IBM®SPSS®software. RESULTS: Positive Nested PCR results for cases and controls were respectively 33.3% and 4.7%, there by  significant difference between cases and controls   infection was identified (p <0.05). Data analysis also showed that tobacco could act synergically with C. pneumoniae infection as a risk factor of lung cancer. In fact a significant difference between patients and controls was shown for tobacco and alcohol use (p < 0.05). CONCLUSION: C. pneumoniae infection is potentially associated with primary Lung cancer in the Moroccan population and has combined effects with Tabaco consumption.


Subject(s)
Chlamydia , Lung Neoplasms , Humans , Lung Neoplasms/epidemiology , Lung Neoplasms/etiology , Alcohol Drinking , Data Analysis , Inflammation , Nicotiana
2.
Pan Afr Med J ; 36: 84, 2020.
Article in French | MEDLINE | ID: mdl-32774643

ABSTRACT

Primary naso-sinusal tuberculosis (TB) is a relatively rare or exceptional disorder characterized by polymorphic or non-specific clinical manifestation. Diagnosis is based on anatomo-pathological examination and mycobacteriology test of biopsy specimen. Predictor of good outcome is early conventional anti-tuberculous antibiotic therapy. However, our study reports recurrence at this rare site in an immunocompetent patient despite early suitable TB treatment and good adherence with therapy. Relapse was correlated with underdosing of rifampicin. This study highlights the diagnostic, etiological and therapeutic management of this relapse. Our experience could help clinicians to better manage this uncommon condition.


Subject(s)
Antitubercular Agents/administration & dosage , Paranasal Sinus Diseases/drug therapy , Rifampin/administration & dosage , Tuberculosis/drug therapy , Dose-Response Relationship, Drug , Female , Humans , Medication Adherence , Middle Aged , Paranasal Sinus Diseases/microbiology , Recurrence , Tuberculosis/microbiology
4.
Pan Afr Med J ; 23: 159, 2016.
Article in English | MEDLINE | ID: mdl-27375831

ABSTRACT

Kartagener syndrome is an autosomal recessive genetic ciliary disorder comprising of a classic triad of sinusitis, situs inversus and bronchiectasis. It's the one of primary ciliary dyskinesia disorders with manifestations present from childhood. Most patients of PCD have situs inversus. We present a case of 18 year-old women with recurrent lower and upper respiratory tracts infections, and rhinolalia clausa.


Subject(s)
Kartagener Syndrome/physiopathology , Respiratory Tract Infections/etiology , Speech Disorders/etiology , Adolescent , Female , Humans , Recurrence , Situs Inversus/etiology
5.
Pan Afr Med J ; 24: 285, 2016.
Article in French | MEDLINE | ID: mdl-28154640

ABSTRACT

Pulmonary involvement in hypocomplementemic urticarial vasculitis (HUV) or Mac Duffie syndrome is extremely rare with a poor prognosis. We report the case of a 55-year-old female patient treated for HUV over a period of 20 years. The diagnosis was confirmed on the basis of urticarial lesions, ocular inflammation, positive C1q-p test by immunodiffusion, with low rate of C1q. The patient was treated with cycles of cyclophosphamide, corticoids and rituximab as she developed class III dyspnea (NYHA classification ). The clinico-radiological and functional assessment showed thoracic distension and severe obstructive pulmonary disease which found no significant improvement with systemic treatment Aerosol therapy was started and the patient had a marked clinical improvement. Pulmonary involvement in Mac Duffie hypocomplementemic urticarial vasculitis worsens the patient short-term vital prognosis. The knowledge of the different types of pulmonary involvement opens new therapeutic prospects.


Subject(s)
Lung Diseases/etiology , Urticaria/pathology , Vasculitis/physiopathology , Adrenal Cortex Hormones/administration & dosage , Adrenal Cortex Hormones/therapeutic use , Complement C1q/deficiency , Cyclophosphamide/administration & dosage , Cyclophosphamide/therapeutic use , Dyspnea/etiology , Female , Humans , Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/therapeutic use , Lung Diseases/drug therapy , Lung Diseases/physiopathology , Middle Aged , Rituximab/administration & dosage , Rituximab/therapeutic use , Syndrome , Urticaria/drug therapy , Vasculitis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL